QT Imaging Q4 revenue jumps 97% sequentially

Reuters
Feb 18
<a href="https://laohu8.com/S/GIAFU">QT Imaging</a> Q4 revenue jumps 97% sequentially

Overview

  • Medical device company's preliminary Q4 revenue rises 97% sequentially

  • Company shipped record 17 scanners in Q4, aiding revenue growth

  • Company relisted on Nasdaq less than a year after leaving exchange

Outlook

  • Company expects 2026 revenue to be approximately $39 mln

  • QT Imaging plans scanner shipments and SaaS Cloud Platform revenue for 2026

Result Drivers

  • SCANNER SHIPMENTS - Record shipment of 17 scanners in Q4 2025 significantly boosted revenue, according to CEO Dr. Raluca Dinu

  • STRATEGIC COLLABORATIONS - Collaborations with Intelerad and Olea Medical enhance SaaS platform, supporting long-term growth strategy

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

$8.28 mln

Q4 EPS

-$0.10

Q4 Net Income

-$1.39 mln

Q4 Operating Income

-$700,000

Q4 Pretax Profit

-$1.39 mln

Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • Wall Street's median 12-month price target for QT Imaging Holdings Inc is $11.60, about 104.4% NOT AVAILABLE its February 17 closing price of $5.68

  • The stock recently traded at 45 times the next 12-month earnings vs. a P/E of 682 three months ago

Press Release: ID:nBw1ZZDcGa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10